Yes. Just thank you very much for having us here again this year, especially at such an exciting time in the company's growth. I feel like every year, we're saying, it's an incredible time for the ...
MILWAUKEE, Jan. 21, 2025 (GLOBE NEWSWIRE) -- Twin Disc, Inc. (NASDAQ: TWIN), today announced that it will release its fiscal 2025 second-quarter results at approximately 8:00 am Eastern on February 5, ...
Disc Medicine, Inc. will hold a conference call on January 21, 2025, at 8:00 am EST to discuss feedback from the FDA regarding its investigational drug, bitopertin, for treating Erythropoietic ...
Disc Medicine announces positive updates on bitopertin, DISC-0974, and DISC-3405, with plans for upcoming clinical trials and data presentations. Disc Medicine, Inc. recently provided positive updates ...